journal article·2026-07Open access

Noble metal nanoparticles in oral cancer: Advances in diagnosis and therapeutic applications – A review

Enas Ismail, Mai Ahmed, Amir Elzwawy, Huda R.M. Rashdan, Christine R. Youssef, Manogari Chetty

Abstract

Oral cancer is one of the major health issues confronting the world nowadays. The restrictions of conventional instruments highlight the demand for novel approaches such as nanotechnology, despite the availability of conventional diagnostic routes and standard treatment modalities (e.g. chemotherapy and radiotherapy). Noble metal nanoparticles (NPs), counting gold (Au), silver (Ag), and platinum group metals (PGMs), have garnered significant consideration for their role in early cancer detection, real-time monitoring, and advanced therapeutic approaches. This review provides a comprehensive overview of recent advancements in the application of noble metal nanoparticles (NPs) for oral cancer diagnosis and treatment, with a primary emphasis on the research published between 2014 and 2025. The review covered the role of different noble metals in oral cancer treatment, encompassing metal-based chemotherapy, photothermal therapy, and related emerging strategies. Besides, the review summarizes the mechanisms of action of noble metal NPs in oral cancer therapy, addressing critical pathways such as metal uptake and efflux, oxidative stress-induced DNA damage, and detoxification. Furthermore, this review explores essential factors in nanoparticle synthesis, emphasizing the relationship between NPs characteristics and their effectiveness in cancer applications. A thorough discussion of the most common synthesis methods for noble metal NPs and their relevance to cancer therapy is also provided. This review stresses the challenges for promising applications, including nanoparticle stability, large-scale production, and clinical implementation. Gold nanoparticles are proposed as precise photothermal and drug delivery applications, while silver nanoparticles offer cytotoxic and antimicrobial assets. Platinum-based nanostructures augment chemotherapy results, and palladium nanoparticles contribute to photodynamic and catalytic therapeutic strategies. The review highlights the necessity for further clinical trials to optimize the efficiency and biocompatibility of noble metal nanoparticles, identifying key knowledge gaps which present important areas for future research and development. • Reviews recent advances (2014–2025) in noble metal nanoparticles for oral cancer diagnosis and therapy. • Explains mechanisms of action, including nanoparticle uptake, oxidative stress, and DNA damage pathways. • Discusses synthesis strategies and how nanoparticle properties affect therapeutic performance. • Identifies challenges and future directions toward clinical translation and patient applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Head and Neck Cancer Studies · Oral Health Pathology and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Understanding carcinogenesis for fighting oral cancer10.1155/2011/603740 ↗
2. Global epidemiology of oral and oropharyngeal cancer10.1016/j.oraloncology.2008.06.002 ↗
3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4. Global patterns and trends in cancers of the lip, tongue and mouth10.1016/j.oraloncology.2019.104551 ↗
5. Head and neck squamous cell carcinoma10.1038/s41572-020-00224-3 ↗
6. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study10.1002/hed.24589 ↗
7. Cancer statistics
8. Ndui · 2011
9. The burden of oral cancer in Sub-Saharan Africa: an estimate as presented to the Global Oral Cancer Forum, March 2016
10. A survey of the awareness and knowledge of oral cancer among residents in Beijing10.1186/s12903-022-02398-6 ↗
11. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case–control study from India10.1016/j.canep.2017.09.003 ↗
12. Oral squamous cell carcinomas: state of the field and emerging directions10.1038/s41368-023-00249-w ↗
13. Oral submucous fibrosis: an update on pathophysiology of malignant transformation10.1111/jop.12582 ↗
14. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer10.1016/j.oraloncology.2021.105469 ↗
15. CLINICAL REVIEW screening for oral cancer
16. Autofluorescence based diagnostic techniques for oral cancer10.4103/0975-7406.163456 ↗
17. A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions—clinical evaluation and review of the literature10.1007/s00784-014-1252-z ↗
18. Highlights in peptide nanoparticle carriers intended to oral diseases10.2174/1568026615666150108125040 ↗
19. Non-invasive techniques for detection and diagnosis of oral potentially malignant disorders10.1620/tjem.238.165 ↗
20. Squamous cell carcinoma of the oral cavity and circulating tumour cells10.5306/wjco.v5.i2.114 ↗
21. Recent advances in noble metal nanoparticles for cancer nanotheranostics10.3390/jnt4020008 ↗
22. Dual-color emissive upconversion nanocapsules for differential cancer bioimaging in vivo10.1021/acsnano.5b07075 ↗
23. Automated analysis of multimodal fluorescence lifetime imaging and optical coherence tomography data for the diagnosis of oral cancer in the hamster cheek pouch model10.1364/BOE.7.002000 ↗
24. Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness10.1038/s41598-017-06534-z ↗
25. Unveiling NIR aza-boron-dipyrromethene (BODIPY) dyes as Raman probes: surface‐enhanced Raman scattering (SERS)‐guided selective detection and imaging of human cancer cells10.1002/chem.201702626 ↗
26. Recent advances in the development of noble metal NPs for cancer therapy10.1155/2022/2444516 ↗
27. A repertoire of biomedical applications of noble metal nanoparticles10.1039/C9CC01741K ↗
28. Noble metals in polyoxometalates10.1002/anie.201202750 ↗
29. Trash or treasure? Sustainable noble metal recovery10.1039/D3GC04950G ↗
30. Gold nanomaterials for oral cancer diagnosis and therapy: advances, challenges, and prospects
31. Noble metal nanomaterials for the diagnosis and treatment of hematological malignancies10.31083/j.fbl2702040 ↗
32. Noble metal complexes in cancer therapy: unlocking redox potential for next-gen treatments10.3390/inorganics13020064 ↗
33. Gold nanorod-based multiplex bioanalytical assay for the detection of CYFRA 21-1 and CA-125: towards oral cancer diagnostics10.1039/D2AY01216B ↗
34. Research progress on silver nanoparticles in the prevention and treatment of oral diseases10.54097/fhmcpv26 ↗
35. Noble metals in pharmaceuticals: applications and limitations
36. Nanomaterials-based advanced systems for photothermal/photodynamic therapy of oral cancer
37. Progress of nanomaterials-based photothermal therapy for oral squamous cell carcinoma10.3390/ijms231810428 ↗
38. Platinum-based chemotherapy induces demyelination of Schwann cells in oral squamous cell carcinoma treatment10.1016/j.taap.2023.116751 ↗
39. Synthesis and anticancer activity of oral Pt (IV) prodrugs containing α-furancarboxylate as an axial ligand10.2174/0115701808257585231016055814 ↗
40. Anticancer effect of novel platinum nanocomposite beads on oral squamous cell carcinoma cells10.1002/jbm.b.34320 ↗
41. Polymorphism of transporter genes contributes to variations in treatment outcomes and adverse events in platinum based-chemotherapy-treated oral cancer patients10.1080/28354311.2023.2292798 ↗
42. Anticancer efficacy of noble metal nanoparticles relies on reprogramming tumor-associated macrophages through redox pathways and pro-inflammatory cytokine cascades10.1038/s41423-018-0046-7 ↗
43. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future10.1039/c2cs15355f ↗
44. The role of gold in alchemy. Part I10.1007/BF03214684 ↗
45. Effect of silver on burn wound infection control and healing: review of the literature10.1016/j.burns.2006.06.010 ↗
46. The elements
47. Functionalization of cotton fabric using the biogenic synthesized silver nanoparticles for enhanced dye reduction and antimicrobial efficiency: response surface methodology10.1016/j.ijbiomac.2025.141853 ↗
48. Wood · 2004
49. Balamurugan · 2009
50. Metal cofactors trafficking and assembly in the cell: a molecular view10.1515/pac-2018-0720 ↗
51. Catalytic and biological activity of organic complexes of precious metals (A review)10.1023/B:PHAC.0000016065.86813.20 ↗
52. Strategic role of selected noble metal nanoparticles in medicine
53. Adaptive changes induced by noble-metal nanostructures in vitro and in vivo10.7150/thno.42569 ↗
54. Metals in cells: control of cellular metal concentration
55. Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru (II) antitumor complexes containing a terphenyl ligand10.1021/mp200105d ↗
56. Development of a FRET-based ratiometric fluorescent probe to monitor the changes in palladium (II) in aqueous solution and living cells10.1039/C8NJ04866E ↗
57. Favorable biological performance regarding the interaction between gold nanoparticles and mesenchymal stem cells10.3390/ijms24010005 ↗
58. Silver nanoparticles impede phorbol myristate acetate-induced monocyte–macrophage differentiation and autophagy10.1039/C5NR04200C ↗
59. Exposure to silver nanoparticles affects viability and function of natural killer cells, mostly via the release of ions10.1007/s10565-017-9403-z ↗
60. Silver nanoparticle exposure induces neurotoxicity in the rat hippocampus without increasing the blood-brain barrier permeability10.1166/jbn.2018.2563 ↗
61. Silver nanoparticles at sublethal concentrations disrupt cytoskeleton and neurite dynamics in cultured adult neural stem cells10.1016/j.neuro.2015.04.008 ↗
62. Microcellular environmental regulation of silver nanoparticles in cancer therapy: a critical review10.3390/cancers12030664 ↗
63. Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy10.1186/s12951-020-00719-x ↗
64. Toropov · 2019 · 61
65. Recent advancements in the plant-based synthesis and mechanistic insights of noble metal nanoparticles and their therapeutic applications10.1016/j.inoche.2024.113594 ↗
66. Advancements in the synthesis and functionalization of zinc oxide-based nanomaterials for enhanced oral cancer therapy10.3390/molecules29112706 ↗
67. Cytotoxicity of plant-mediated synthesis of metallic nanoparticles: a systematic review10.3390/ijms19061725 ↗
68. Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells10.3390/nano11040964 ↗
69. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum (IV) complexes10.1016/S0021-9258(18)96186-7 ↗
70. Synthesis, bioactive properties, and biomedical applications of intrinsically therapeutic nanoparticles for disease treatment10.1016/j.cej.2022.134970 ↗
71. Non-platinum chemotherapeutic metallopharmaceuticals10.1021/cr9804238 ↗
72. Cytotoxicity and targeted drug delivery of green synthesized metallic nanoparticles against oral cancer: a review10.1016/j.inoche.2024.113806 ↗
73. Unveiling the chemotherapeutic potential of two platinum (IV) complexes in skin cancer: in vitro and in vivo insights10.1016/j.crphar.2024.100205 ↗
74. Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm10.1016/j.biomaterials.2024.122835 ↗
75. Platinum (II) complexes based on derivatives of natural chlorins with pyridine-containing chelate groups as prototypes of drugs for combination therapy in oncology, fine
76. Recent advancements in nanotechnology-mediated platinum-based cancer therapy
77. Ultrasmall platinum nanoclusters: a potent chemotherapeutic drug for cancer-specific DNA damage with optimizing therapeutic efficacy while minimizing systemic toxicity10.1016/j.nantod.2024.102195 ↗
78. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli10.1016/j.colsurfb.2009.07.048 ↗
79. Biocompatible silver, gold and silver/gold alloy nanoparticles for enhanced cancer therapy: in vitro and in vivo perspectives10.1039/C7NR04979J ↗
80. Green synthesis of silver and gold nanoparticles and their potential applications as therapeutics in cancer therapy; a review10.1016/j.inoche.2022.109610 ↗
81. Evaluation of gold, silver and silver–gold (bimetallic) nanoparticles as radiosensitizers for radiation therapy in cancer treatment10.13189/cor.2016.040302 ↗
82. Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of Annona muricata. L against squamous cell carcinoma cell line 15 through apoptotic pathway10.4103/drj.drj_521_23 ↗
83. Combined miR-181a-5p and ag nanoparticles are effective against oral cancer in a mouse model10.2147/IJN.S458484 ↗
84. Green synthesis of gold nanoparticles and their biomedical applications
85. Gold-based nanoparticles and their applications in cancer therapy
86. Gold and silver nanoparticles for biomedical applications
87. Role of gold nanoparticles as novel agents for cancer diagnosis and therapy
88. Advanced nanomaterials for cancer therapy: gold, silver, and iron oxide nanoparticles in oncological applications
89. RUTHENIUM ORGANOMETALLIC COMPOUNDS IN CANCER TREATMENT, biomed
90. Ruthenium (II) complex with 1-Hydroxy-9, 10-Anthraquinone inhibits cell cycle progression at G0/G1 and induces apoptosis in Melanoma cells10.3390/ph18010063 ↗
91. From concept to cure: the road ahead for ruthenium‐based anticancer drugs10.1002/cmdc.202400435 ↗
92. Investigating the antitumor effects of a novel ruthenium (II) complex on malignant melanoma cells: an NMR-based metabolomic approach10.1016/j.bbrc.2023.149169 ↗
93. Ruthenium-based complexes as anti-tumor agents
94. Sustainable mechanistic insights into the anticancer and antimicrobial activities of ruthenium and palladium compounds
95. Molecular studies regarding colon cancer cell line (HCT116) treated by new ruthenium and palladium complexes10.1002/aoc.7173 ↗
96. Rhodium (I) complexes containing the N^ N^ N-Chelating ligand: synthesis, structure, and biological activity10.1021/acs.organomet.3c00430 ↗
97. Rhodium (III)–picolinamide complexes act as anticancer and antimetastasis agents via inducing apoptosis and autophagy10.1021/acs.jmedchem.3c00318 ↗
98. Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance10.1039/D4TB01631A ↗
99. Rhodium–tellurium nanorod synthesis using galvanic replacement-polyol regrowth for thermo-dynamic dual-modal cancer phototherapy10.1021/acsami.2c07281 ↗
100. Recent advances in anticancer research of osmium and rhodium complexes10.2174/0115734064327558240826050650 ↗